Application of Huangqi Compatible Prescription in Chronic Kidney Disease

Abstract

Abstract: Chronic kidney disease (CKD) is a kind of insidious and slow-progressing disease caused by many causes. Its incidence is high and rising year by year.It has become an important public health problem in China. Traditional Chinese medicine has long been used in the treatment of chronic kidney disease, and its exact curative effect has been recognized by the majority of patients. Huangqi has the effects of regulating immunity,anti-oxidation,reducing proteinuria,anti-fibrosis and anti-inflammation in chronic kidney disease. By analyzing the flexible application and subtle compatibility of Huangqi in Chinese medicine in this paper, we hope to better guide the clinical application of Huangqi compatibility in chronic kidney disease.

Key words: Huangqi, compatibility, prescription, chronic kidney disease

CLC Number:

R259
R277.5

LIU Shan-lin, QU Bo, HE Jin-shi, YAN Bo-nan, HE Yu-hua. Application of Huangqi Compatible Prescription in Chronic Kidney Disease[J]. ZHONGHUA YANGSHENG BAOJIAN, 2024, 42(12): 158-162.

References

[1] 周涵,梁伟.慢性肾脏病与高尿酸血症[J].临床内科杂志,2023,40(6): 374-378.
[2] WANG L, XU X, ZHANG M, et al.Prevalence of Chronic Kidney Disease in China: Results From the Sixth China Chronic Disease and Risk Factor Surveillance[J].JAMA Intern Med,2023,183(4):298-310.
[3] 陈金娜,谢丽萍,黄源铭,等.中医药治疗慢性肾衰竭的研究进展[J].实用中医内科杂志,2024,38(1):81-83.
[4] 徐进,蒋春波.中药黄芪治肾病“机理”说[J].陕西中医药大学学报,2022,45(2):127-131.
[5] 来洁,王安妮,朱梦洁,等.消瘀泄浊饮对慢性肾脏病2~4期患者Th17/Treg细胞免疫平衡的影响[J].浙江中医药大学学报,2021,45(7):761-764,791.
[6] 王恒. 中西医结合治疗慢性肾脏病的临床效果[J].内蒙古中医药,2021,40(10):57-59.
[7] 田丹. 温针灸治疗CKD3-5期非透析患者胃肠道症状的临床观察[D].哈尔滨:黑龙江中医药大学,2023.
[8] 霍长亮,陈波,江桂林,等.中药浴足治疗慢性肾功能衰竭40例临床观察[J].浙江中医药大学学报,2014,38(2):165-167.
[9] 闫丽丽. 黄芪炮制方法研究进展[J].农业科技与装备,2019(2):65-66.
[10] 徐国钧,徐珞珊.常用中药材品种整理和质量研究.南方协作组.第一册[D].福州:福建科学技术出版社,1994:148.
[11] 朱雪萍,王新华,林吉祥,等.黄芪注射液对透析患者免疫功能的作用[J].实用中医内科杂志,2001,15(1):9-10.
[12] 刘红,孙伟,顾刘宝,等.黄芪治疗慢性肾脏病机制及其延缓细胞衰老研究[J].中华肾病研究电子杂志,2014,3(6):328-331.
[13] 高崇婷,桂定坤,汪年松,等.黄芪皂苷Ⅱ对STZ诱导的糖尿病大鼠的肾脏保护作用研究[J].现代生物医学进展,2020,20(23):4401-4406,4417.
[14] 杨蓉,倪兆慧,钱家麒,等.人类转化生长因子β诱导基因-克隆3在糖尿病大鼠肾组织中的表达以及洛沙坦和黄芪对其影响[J].中华肾脏病杂志,2004,20(5):39-42.
[15] 左川,邱红渝,谢席胜,等.黄芪对UUO模型大鼠肾脏肝细胞生长因子表达的影响[J].四川大学学报(医学版),2009,40(1):100-105.
[16] 赖琦. 黄芪甲苷通过诱导自噬抗炎的作用及机制研究[D].昆明:云南中医学院,2018.
[17] 李长明,李玲孺,姚海强,等.历代医案应用玉屏风散调体治病探微[J].吉林中医药,2016,36(2):121-124.
[18] 毕玉霞,周德忠,许剑琴.“玉屏风散”对机体免疫功能的影响[J].中兽医学杂志, 2006(1):38-40.
[19] 吴敬芳. 叶传蕙教授用玉屏风散治疗肾脏病经验[J].河南中医,2008,193(1):19-20.
[20] 郭广宇,杨洪涛.防己黄芪汤治疗肾脏疾病研究进展[J].实用中医药杂志,2022,38(8):1453-1455.
[21] 杨向利,梁亚妮.肾病综合征中防己黄芪汤的应用与药理分析[J].北方药学,2021,18(5):15-16.
[22] 张蕊,王子承,蒋荣莉,等.防己黄芪汤加味治疗糖尿病肾病疗效及对患者糖脂代谢、氧化应激的影响[J].陕西中医,2021,42(8):1049-1052.
[23] 安海文. 黄芪当归汤治疗维持性血液透析患者脾肾气虚型营养不良临床观察[J].山西中医,2016,32(5):10-12,14.
[24] 高艳霞,蔡宏瑜,万强.黄芪山甲汤治疗慢性肾脏病75例临床观察[C]//中国中西医结合学会肾脏疾病专业委员会.中国中西医结合学会肾脏疾病专业委员会2011年学术年会暨2011年国际中西医结合肾脏病学术会议论文汇编. 2011:1.
[25] 方明明. 参芪地黄汤化裁方对肾间质纤维化大鼠ERK通路和AngAT1的影响[D].哈尔滨:黑龙江省中医药科学院,2018.
[26] 李鸣,李亮,李伟男,等.参芪地黄汤治疗IgA肾病作用机制的网络药理学研究[J].中国医药导报,2021,18(29):8-13,197-198.
[27] 王燕平,叶品良,卢振方,等.基于“元气非胃气不能滋”探讨补中益气汤在肾病中的应用[C].哈尔滨:中华中医药学会第十四次中医方剂学学术年会论文集, 2014.
[28] 刘伟伟,史丽强,万强,等.基于NLRP3炎性体探究黄芪桂枝五物汤对IgA肾病小鼠肾脏保护机制[J].中华中医药杂志,2018,33(5):1746-1751.
[29] 许文倩,胡英还,秦雪梅,等.黄芪建中汤临床应用及实验研究进展[J].山西中医学院学报,2018,19(2):67-71.
[30] 承忠委,承荷清.黄芪建中汤临床应用举隅[J].吉林中医药,1986(3):22-23.
[31] 张英杰,张宗礼.黄芪建中汤加减联合西医常规治疗脾肾阳虚型肾病综合征的经验总结[J].内蒙古中医药,2019,38(12):91-92.